Skip to Content

Triptodur Approval History

FDA Approved: Yes (First approved June 29, 2017)
Brand name: Triptodur
Generic name: triptorelin
Dosage form: Injection
Company: Arbor Pharmaceuticals, LLC
Treatment for: Precocious Puberty

Triptodur (triptorelin) is a gonadotropin releasing hormone (GnRH) agonist indicated for the treatment of pediatric patients with central precocious puberty.

Development History and FDA Approval Process for Triptodur

DateArticle
Jun 30, 2017Approval Arbor Pharmaceuticals, LLC Announces FDA Approval for Triptodur (triptorelin)

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide